Sabra Health Care REIT, Inc.
SBRA
$17.27
$0.342.01%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 96.07M | 94.56M | 99.10M | 91.78M | 93.04M |
Total Other Revenue | 86.88M | 83.66M | 77.13M | 74.38M | 69.60M |
Total Revenue | 182.95M | 178.22M | 176.22M | 166.15M | 162.64M |
Cost of Revenue | 59.71M | 58.36M | 54.59M | 53.86M | 49.52M |
Gross Profit | 123.24M | 119.86M | 121.63M | 112.30M | 113.12M |
SG&A Expenses | 13.03M | 12.40M | 12.74M | 11.89M | 16.68M |
Depreciation & Amortization | 42.31M | 42.72M | 41.68M | 42.91M | 42.88M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 115.05M | 113.48M | 109.01M | 108.66M | 109.08M |
Operating Income | 67.90M | 64.74M | 67.21M | 57.49M | 53.56M |
Income Before Tax | 47.08M | 29.52M | 24.41M | 26.71M | 17.65M |
Income Tax Expenses | 380.00K | -265.00K | 437.00K | 453.00K | 493.00K |
Earnings from Continuing Operations | 46.70M | 29.79M | 23.98M | 26.25M | 17.16M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 46.70M | 29.79M | 23.98M | 26.25M | 17.16M |
EBIT | 67.90M | 64.74M | 67.21M | 57.49M | 53.56M |
EBITDA | 105.34M | 107.46M | 108.89M | 100.41M | 90.62M |
EPS Basic | 0.20 | 0.13 | 0.10 | 0.11 | 0.07 |
Normalized Basic EPS | 0.11 | 0.09 | 0.10 | 0.08 | 0.07 |
EPS Diluted | 0.20 | 0.13 | 0.10 | 0.11 | 0.07 |
Normalized Diluted EPS | 0.11 | 0.09 | 0.10 | 0.08 | 0.07 |
Average Basic Shares Outstanding | 236.60M | 234.29M | 231.62M | 231.45M | 231.22M |
Average Diluted Shares Outstanding | 239.64M | 237.04M | 233.75M | 233.37M | 233.20M |
Dividend Per Share | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
Payout Ratio | 152.00% | 235.93% | 289.68% | 264.51% | 404.34% |